首页> 外文期刊>Open access Journal of Contraception >An update on the potential for male contraception: emerging options
【24h】

An update on the potential for male contraception: emerging options

机译:男性避孕潜力的最新动态:新出现的选择

获取原文
           

摘要

Abstract: The human population continues to grow and is estimated to rise to 10.1 billion by the end of the century. Therefore, there is still an unmet need for safe and highly effective contraceptive options for both men and women. Current options available to men include withdrawal, condoms, and vasectomy. Methods in development fall into two categories: hormonal and nonhormonal. This review will provide an overview of the testosterone combinations and immunocontraception of hormonal targets. Nonhormonal immunocontraception of sperm proteins will also be examined, together with the use of agents to disrupt other sperm-associated targets and pathways. The categories focused on include epididymal proteins, testicular kinases, epigenetic reader proteins, opioids, lonidamine derivatives, retinoic acid, microRNAs associated with spermatogenesis, and plant extracts. Considering these developments, the number of options available to men is likely to increase in the near future.
机译:【摘要】人口持续增长,到本世纪末估计将达到101亿。因此,对于男人和女人而言,仍然存在对安全有效的避孕选择的未满足需求。男性目前可用的选择包括戒断,避孕套和输精管切除术。发展中的方法分为两类:激素和非激素。这篇综述将概述睾丸激素组合和激素靶点的免疫避孕。还将研究精子蛋白的非激素免疫避孕方法,以及使用试剂破坏其他与精子相关的靶标和途径的方法。重点关注的类别包括附睾蛋白质,睾丸激酶,表观遗传阅读器蛋白质,阿片类药物,Lonidamine衍生物,视黄酸,与精子发生有关的microRNA和植物提取物。考虑到这些发展,在不久的将来,男性可用的选择数量可能会增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号